Related StoriesCancer DNA in individual's bloodstream may help deliver personalized treatment for liver cancerDNA assessment for Straight down's syndrome may potentially conserve lives of unborn babiesNuclear membrane fixes potentially fatal breaks in DNA strandsAMP commends the SACGHS when planning on taking a strong stance against business methods that harm patients, restrict development and reduce access to life saving tests. AMP President Dr. Jan Nowak commented, This statement is a milestone in our attempts to improve access to genetic tests. The risk of enforcement from a patent holder and the ensuing litigation costs has generated a chilling effect on medical laboratories producing us reluctant to build up new testing that could directly advantage patients.Riggs, President and CEO of Advanced Tumor Therapeutics. These agreements are central to the timely and efficient development of a novel vaccine and we look forward to continuing our collaborations as we work towards this common objective. The first agreement announced today is with the University of Louisville’s James Graham Dark brown Cancer Center and grants ACT exceptional worldwide advancement and commercialization rights to monovalent vaccines produced from the minor capsid proteins of individual papillomavirus.